E84G mutation in dihydrofolate reductase from drug resistant strains of Mycobacterium tuberculosis (Mumbai, India) leads to increased interaction with Trimethoprim
Background: Dihydrofolate reductase (DHFR) (dfrA gene) is an essential enzyme for cell survival and an unexplored target in Mycobacterium tuberculosis (Mtb). This study was carried out to analyze mutations in the dfrA gene amongst 20 clinical DNA samples from Mtb isolates obtained from Mumbai, India...
Main Authors: | Archana Raju, Savita Kulkarni, M K Ray, M G.R Rajan, Mariam S Degani |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2015-01-01
|
Series: | International Journal of Mycobacteriology |
Subjects: | |
Online Access: | http://www.ijmyco.org/article.asp?issn=2212-5531;year=2015;volume=4;issue=2;spage=97;epage=103;aulast=Raju |
Similar Items
-
Dihydrofolate Reductase Inhibitors: The Pharmacophore as a Guide for Co-Crystal Screening
by: João A. Baptista, et al.
Published: (2021-11-01) -
A calibration curve for immobilized dihydrofolate reductase activity assay
by: Priyanka Singh, et al.
Published: (2015-09-01) -
Trimethoprim: An Old Antibacterial Drug as a Template to Search for New Targets. Synthesis, Biological Activity and Molecular Modeling Study of Novel Trimethoprim Analogs
by: Agnieszka Wróbel, et al.
Published: (2019-12-01) -
New Trimethoprim-Like Molecules: Bacteriological Evaluation and Insights into Their Action
by: Marta Jorba, et al.
Published: (2021-06-01) -
INHIBITORY ACTIVITY OF SOME MARINE SPONGE EXTRACTS FROM URABÁ GULF ON DIHYDROFOLATE REDUCTASE ENZYME
by: Diego A. ZABALA, et al.
Published: (2009-02-01)